Purchases and Sales Made in Q1 2023 in Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS) during Q1 2023. The information is specifically focused on institutions that hold shares of Tarsus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 10, 2023
Q1 2023
|
Swiss National Bank
Zurich, V8 |
SELL
|
- |
-4.4K- 10.52% |
$52.4K - $71.6K
|
37.4K
$1.91M
|
|
|
May 15, 2023
Q1 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-5.19K- 10.57% |
$61.8K - $84.4K
|
43.9K
$2.24M
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-10.5K- 92.15% |
$125K - $170K
|
891
$45.4K
|
|
|
Apr 27, 2023
Q1 2023
|
Strs Ohio
|
SELL
|
- |
-19.3K- 83.55% |
$230K - $314K
|
3.8K
$194K
|
|
|
May 15, 2023
Q1 2023
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-22.9K- 13.25% |
$273K - $373K
|
150K
$7.65M
|
|
|
May 11, 2023
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-27.1K- 48.69% |
$323K - $441K
|
28.6K
$1.46M
|
|
|
May 14, 2024
Q1 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-27.1K- 48.69% |
$323K - $441K
|
28.6K
$1.46M
|
|
|
Apr 18, 2023
Q1 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-37K- 20.2% |
$441K - $602K
|
146K
$7.45M
|
|
|
May 12, 2023
Q1 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-63.2K- 22.21% |
$754K - $1.03M
|
221K
$11.3M
|
|
|
May 15, 2023
Q1 2023
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-168K- 12.7% |
$2M - $2.74M
|
1.16M
$58.9M
|
|
|
May 10, 2023
Q1 2023
|
Times Square Capital Management, LLC
|
SELL
|
- |
-237K- 16.56% |
$2.82M - $3.85M
|
1.19M
$60.8M
|
|
|
May 15, 2023
Q1 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-315K- 18.14% |
$3.75M - $5.13M
|
1.42M
$72.5M
|